Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J (2019) Nasopharyngeal carcinoma. Lancet 394:64–80
2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209–249
3. Caudell JJ, Gillison ML, Maghami E, Spencer S, Pfister DG, Adkins D et al (2022) NCCN Guidelines(R) insights: head and neck cancers, version 1.2022. J Natl Compr Canc Netw 20:224–234
4. Bao Y, Peng F, Zhou QC, Yu ZH, Li JC, Cheng ZB et al (2015) Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer. Radiother Oncol 114:161–166
5. Wang J, Sun Y, Liu Y, Yu Q, Zhang Y, Li K et al (2005) Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients. Zhongguo Fei Ai Za Zhi 8:283–290